- Home
- AMBA vs CPRX Comparison
AMBA vs CPRX Comparison
Compare AMBA & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBA
- CPRX
- Stock Information
- Founded
- AMBA 2004
- CPRX 2002
- Country
- AMBA United States
- CPRX United States
- Employees
- AMBA N/A
- CPRX N/A
- Industry
- AMBA Semiconductors
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBA Technology
- CPRX Health Care
- Exchange
- AMBA Nasdaq
- CPRX Nasdaq
- Market Cap
- AMBA 3.3B
- CPRX 2.9B
- IPO Year
- AMBA N/A
- CPRX 2006
- Fundamental
- Price
- AMBA $52.64
- CPRX $24.96
- Analyst Decision
- AMBA Buy
- CPRX Strong Buy
- Analyst Count
- AMBA 12
- CPRX 7
- Target Price
- AMBA $80.83
- CPRX $32.29
- AVG Volume (30 Days)
- AMBA 856.7K
- CPRX 1.1M
- Earning Date
- AMBA 05-29-2025
- CPRX 05-07-2025
- Dividend Yield
- AMBA N/A
- CPRX N/A
- EPS Growth
- AMBA N/A
- CPRX 178.13
- EPS
- AMBA N/A
- CPRX 1.57
- Revenue
- AMBA $316,264,000.00
- CPRX $534,645,999.00
- Revenue This Year
- AMBA $20.37
- CPRX $16.37
- Revenue Next Year
- AMBA $11.56
- CPRX $8.80
- P/E Ratio
- AMBA N/A
- CPRX $15.91
- Revenue Growth
- AMBA 44.54
- CPRX 29.97
- 52 Week Low
- AMBA $38.86
- CPRX $14.75
- 52 Week High
- AMBA $85.15
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- AMBA 39.68
- CPRX 59.49
- Support Level
- AMBA $60.88
- CPRX $23.76
- Resistance Level
- AMBA $63.64
- CPRX $25.00
- Average True Range (ATR)
- AMBA 2.56
- CPRX 0.72
- MACD
- AMBA -0.67
- CPRX 0.05
- Stochastic Oscillator
- AMBA 13.48
- CPRX 86.76
About AMBA Ambarella Inc.
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).